gray market glp 1 Glucagon-like peptide-1 (GLP-1) injectable medications have shown a lot of promise for managing chronic conditions like diabetes and obesity. But their popularity and price has spurred many lookalikes that are not GLP-1s GLP-1 Analogues Market Size, Share

Conclusion and Future Directions With the recent increase in GLP-1 RA use, it is essential to explore and understand the impact of these medications on the performance of gastrointestinal procedures such as EGD and colonoscopy

The more cautious interpretation is that patients who receive GLP-1 receptor agonists may differ in important but incompletely measured ways from those treated with insulin or metformin, including overall health, treatment access, healthcare follow-up, or cardiometabolic care intensity

Claim: it lessens inflammation. Truth: not really

In the CNS, endogenous GLP-1 acts primarily through vagal afferent signaling, transmitting information from the gastrointestinal tract to the brainstem [123, 124]

First, the treatment sequence and interaction term between the trial arm and sequence were included to account for a carryover effect of the study drug